感染性休克患者早期启动去甲肾上腺素:基于倾向性评分的分析
该研究从MIMIC-IV数据库纳入2008至2019年4253例感染性休克患者,采用倾向性评分匹配比较早期(3小时内)与延迟(>3小时)启动去甲肾上腺素对生存的影响。匹配后每组1431例,早期组28天死亡率30.0% vs 延迟组37.8%,生存天数更长(21.89 vs 20.37天),ICU住院时间更短(4.9 vs 7.2天),休克后24小时内器官衰竭进展发生率更低(64.4% vs 79.2%),6和24小时平均动脉压更高(p<0.05)。结论认为3小时内启动去甲肾上腺素与更长生存时间相关,可能延迟或部分逆转快速进展的器官衰竭。
要点
- 倾向性评分匹配后,感染性休克3小时内启动去甲肾上腺素者28天死亡率30.0% vs 延迟组37.8%(p<0.05)。
- 早期组液体治疗量显著更少(0 vs 79 mL/kg),且不依赖前负荷状态。
- 早期组生存天数更长(21.89 vs 20.37天),ICU住院时间更短(4.9 vs 7.2天),总住院时间更短(12.4 vs 13.6天)。
- 早期组休克后24小时内器官衰竭进展发生率更低(64.4% vs 79.2%)。
- 早期组休克后6小时和24小时平均动脉压均更高(p<0.05)。
适用人群与场景
- 选自MIMIC-IV数据库2008至2019年的感染性休克患者,共4253例。
处置流程与药物剂量
- 早期启动去甲肾上腺素定义为休克发生后3小时内开始给药;延迟启动定义为超过3小时开始给药。
研究设计与关键结果
- 研究类型为基于MIMIC-IV数据库的倾向性评分匹配分析,纳入4253例感染性休克患者。
- 倾向性评分匹配后2862例患者均分至早期组(3小时内启动去甲肾上腺素)和延迟组(>3小时启动),每组1431例。
- 主要终点28天死亡率:早期组30.0% vs 延迟组37.8%(p<0.05)。
- 早期组液体治疗量显著少于延迟组(0 vs 79 mL/kg)。
- 早期组生存天数长于延迟组(21.89 vs 20.37天),ICU住院时间短于延迟组(4.9 vs 7.2天),住院时间短于延迟组(12.4 vs 13.6天)。
- 早期组支持性去甲肾上腺素使用时间和有创机械通气时间均短于延迟组。
- 早期组休克后24小时内器官衰竭进展发生率低于延迟组(64.4% vs 79.2%),休克后6小时和24小时平均动脉压均高于延迟组(p<0.05)。
证据类型、等级与局限
- 证据类型:基于医学信息集市重症监护IV数据库(MIMIC-IV)的倾向性评分匹配分析。
对床旁实践的改变
- 作者认为,感染性休克患者3小时内启动去甲肾上腺素与更长生存时间、更短支持性去甲肾上腺素使用时间和有创机械通气时间相关,并可能延迟或部分逆转快速进展的器官衰竭,且不依赖前负荷状态。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The use of vasopressors is vital in septic shock. However, the optimal timing of treatment remains unclear. Therefore, we aimed to explore the impact of early norepinephrine initiation on the survival of patients with septic shock.
METHODS: We selected 4253 patients from the Medical Information Mart for Intensive Care IV database between 2008 and 2019. The primary outcome was 28-day mortality. Propensity score matching (PSM) was applied to minimize between-group imbalances, and a restricted mean survival time was used to quantify the beneficial impact of early norepinephrine treatment on survival. Sensitivity analyses were conducted to test the robustness of the study results in multiple cohorts.
RESULTS: In the PSM cohort, 2862 patients were equally assigned to early (receiving norepinephrine within the first 3 h) and delayed (> 3 h) norepinephrine initiation groups. Patients in the early norepinephrine initiation group received significantly less fluid therapy (0 vs. 79 mL/kg), had lower 28-day mortality (30.0% vs. 37.8%), longer survival days (21.89 vs. 20.37 days), shorter duration of intensive care unit (4.9 vs. 7.2 days) and hospital stays (12.4 vs. 13.6 days), shorter duration of supportive norepinephrine and invasive mechanical ventilation, lower incidence of organ failure progression (64.4% vs. 79.2%) within 24 h after shock onset, and higher mean arterial pressure within 6 and 24 h after shock onset than patients in the delayed norepinephrine initiation group (p < 0.05).
CONCLUSIONS: Norepinephrine initiation within the first 3 h, regardless of preload dependency, was associated with longer survival time and shorter duration of supportive norepinephrine and invasive mechanical ventilation and may delay or partially reverse rapid onset organ failure.
参考来源
- Xu F, Zhong R, Shi S, et al. Early initiation of norepinephrine in patients with septic shock: A propensity score-based analysis. Am J Emerg Med. 2022. PMID: 35227959. doi:10.1016/j.ajem.2022.01.063
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。